VIBRATAC: Impact of a Focal Muscle Vibration Protocol in Front of the the Anterior Tibial Muscle in the Subacute Post-stroke Period on Motor Recovery in Hemiplegic Patients.

Sponsor
Centre Hospitalier Universitaire de Saint Etienne (Other)
Overall Status
Recruiting
CT.gov ID
NCT04737018
Collaborator
(none)
30
2
2
22.6
15
0.7

Study Details

Study Description

Brief Summary

In about 40 percent of cases, after a stroke, neuromotor impairment leads to activity limitations and the development of chronic functional disorders, which have a significant impact on patient autonomy.

In the early subacute phase, motor deficit in foot lifters is one of the factors limiting standing posture and ambulation, which is ultimately difficult to rehabilitate due to the lack of available techniques for obtaining early onset of useful active voluntary contraction.

The use of muscular focal vibration therapy, applied to relaxed muscle, may be of interest due to the portability and availability of the system and the neuromotor benefits demonstrated in healthy subjects and in acute and chronic post-stroke patients.

Condition or Disease Intervention/Treatment Phase
  • Other: Fugl-Meyer Assessment (FMA)
  • Other: Medical Research Concil (MRC)
  • Other: 2 Minute Walk Test (2MWT)
  • Other: Timed Up & Go Test
  • Other: Modified Ashworth Scale
  • Other: Postural Assessment Scale for Stroke
  • Device: posturographic recording
  • Other: vibration program
  • Other: sham program
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Impact of a Focal Muscle Vibration Protocol in Front of the the Anterior Tibial Muscle in the Subacute Post-stroke Period on Motor Recovery in Hemiplegic Patients.
Actual Study Start Date :
May 14, 2021
Anticipated Primary Completion Date :
Feb 1, 2023
Anticipated Study Completion Date :
Apr 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: vibration program

a 4-week program of muscular focal vibrations, at the rate of 5 sessions of 30 minutes per week, in addition to conventional rehabilitation. The program will apply a frequency of 100 Hz, with an amplitude of 1 mm

Other: Fugl-Meyer Assessment (FMA)
assessment of motor skills : measurement of the intensity of reflexes, as well as an assessment of voluntary movements and motor coordination Score from 0 to 34

Other: Medical Research Concil (MRC)
evaluation of muscular strength score from 0 to 5

Other: 2 Minute Walk Test (2MWT)
Assess functional walking and aerobic abilities

Other: Timed Up & Go Test
measures the time it takes to get up from a chair, walk 10 feet, turn around, return to the seat and sit down

Other: Modified Ashworth Scale
score from 0 to 4 evaluation of spasticity

Other: Postural Assessment Scale for Stroke
score from 0 to 36 measures the patient's ability to maintain stable postures and balance in changes of position

Device: posturographic recording
analysis of static equilibrium parameters and positional measurement of the center of gravity on the Winposturo platform

Other: vibration program
a 4-week program of muscular focal vibrations, at the rate of 5 sessions of 30 minutes per week, in addition to conventional rehabilitation. The program will apply a frequency of 100 Hz, with an amplitude of 1 mm

Sham Comparator: sham program

a 4-week program of muscular focal vibrations, at the rate of 5 sessions of 30 minutes per week, in addition to conventional rehabilitation.

Other: Fugl-Meyer Assessment (FMA)
assessment of motor skills : measurement of the intensity of reflexes, as well as an assessment of voluntary movements and motor coordination Score from 0 to 34

Other: Medical Research Concil (MRC)
evaluation of muscular strength score from 0 to 5

Other: 2 Minute Walk Test (2MWT)
Assess functional walking and aerobic abilities

Other: Timed Up & Go Test
measures the time it takes to get up from a chair, walk 10 feet, turn around, return to the seat and sit down

Other: Modified Ashworth Scale
score from 0 to 4 evaluation of spasticity

Other: Postural Assessment Scale for Stroke
score from 0 to 36 measures the patient's ability to maintain stable postures and balance in changes of position

Device: posturographic recording
analysis of static equilibrium parameters and positional measurement of the center of gravity on the Winposturo platform

Other: sham program
a 4-week program of muscular focal vibrations, at the rate of 5 sessions of 30 minutes per week, in addition to conventional rehabilitation.

Outcome Measures

Primary Outcome Measures

  1. score of Fugl Meyer Assessment (lower limbs) [day 30]

    score from 0 to 34 Stroke-specific performance-based disability index that quantitatively assesses analytical motor skills in the lower limb.

Secondary Outcome Measures

  1. score of Fugl Meyer Assessment (lower limbs) [day 0, day 15, day 30 and month 2]

    score from 0 to 34 Stroke-specific performance-based disability index that quantitatively assesses analytical motor skills in the lower limb.

  2. score of Medical Research Concil [day 0, day 15, day 30 and month 2]

    score of 0 (absence of contraction) to 5 (normal force)

  3. assess functional walking ability [day 0, day 15, day 30 and month 2]

    measured with 2 Minute Walk Test

  4. score of postural assessment scale for stroke [day 0, day 15, day 30 and month 2]

    measures the patient's ability to maintain stable postures, as well as balance in changes of position score of 0 (cannot perform the activity) to 36 (can perform the activity)

  5. analysis of static equilibrium [day 0, day 15, day 30 and month 2]

    with Winposturo platform

  6. positional measurement of the center of gravity [day 0, day 15, day 30 and month 2]

    with Winposturo platform

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Having had a stroke (with or without previous stroke) and being in the early subacute phase (between 14 days and 3 months of stroke).

  • Responsible for a motor deficit in the right or left lower limb.

  • No neurological history other than stroke.

Exclusion Criteria:
  • Multifocal stroke

  • Patient having received a botulinum toxin injection to the lower limb to be vibrated

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre Hospitalier Universitaire de Saint-Etienne Saint-Etienne France 42055
2 Le Clos Champirol - Service de Médecine Physique et de Réadaptation Saint-Priest-en-Jarez France

Sponsors and Collaborators

  • Centre Hospitalier Universitaire de Saint Etienne

Investigators

  • Principal Investigator: Bruno FERNANDEZ, MD, CHU Saint Etienne

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire de Saint Etienne
ClinicalTrials.gov Identifier:
NCT04737018
Other Study ID Numbers:
  • 20CH152
  • 2020-A03189-30
First Posted:
Feb 3, 2021
Last Update Posted:
Jun 22, 2021
Last Verified:
Apr 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Centre Hospitalier Universitaire de Saint Etienne
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 22, 2021